Phantasmal FlamesPhantasmal Flames🃏All Cresselia cards
Ask about Cresselia
Cresselia #39 Pokémon card from Phantasmal Flames

Cresselia 39/94

Phantasmal Flames

Find this card on eBay

Affiliate link · we may earn commission

Cresselia #39 from Phantasmal Flames currently trades at $0.20 raw, with PSA 10 copies reaching $48.00 — a 240.0x grade premium.
Current Prices (USD)
Ungraded
$0.20
PSA 7
$10.36
PSA 8
$10.36
PSA 9
$10.36
PSA 10
$48.00
ACE 10
BGS 10 Black
$310.00
CGC 10 Pristine
$52.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Cresselia 39/94 from Phantasmal Flames has a current raw market value of $0.20.

Current raw value
$0.20
PSA 9 value
$10.36
PSA 10 value
$48.00
View all cards from Phantasmal Flames
Collector Intel
240.0x
Raw → PSA 10
High-risk grade
51.8x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 240x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$48
PSA 10 Value
+$23
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1051.8x raw
PSA 10$48240.0x raw

Frequently asked questions

How much is Cresselia #39 from Phantasmal Flames worth?+
Cresselia #39 from Phantasmal Flames is currently worth Raw: $0.20, PSA 9: $10.36, PSA 10: $48.00 based on recent sold listings. Prices update daily from real eBay sales.
Is Cresselia #39 worth grading?+
The PSA 10 price of $48.00 is 240.0× the raw price of $0.20. After a ~$25 grading fee, a PSA 10 result would net approximately $47.80 — assuming the card grades a 10.
Where do PokePrices Cresselia #39 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.